关注
Helen Tang
Helen Tang
在 pennmedicine.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genetic and transcriptional evolution alters cancer cell line drug response
U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ...
Nature 560 (7718), 325-330, 2018
8212018
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Y Cohen-Sharir, JM McFarland, M Abdusamad, C Marquis, SV Bernhard, ...
Nature 590 (7846), 486-491, 2021
1692021
Randomised, double-blind, placebo-controlled trial of probiotics to eliminate COVID-19 transmission in exposed household contacts (PROTECT-EHC): a clinical trial protocol
H Tang, L Bohannon, M Lew, D Jensen, SH Jung, A Zhao, AD Sung, ...
BMJ open 11 (5), e047069, 2021
352021
Daily Lactobacillus probiotic versus placebo in COVID-19-exposed household contacts (PROTECT-EHC): a randomized clinical trial
PE Wischmeyer, H Tang, Y Ren, L Bohannon, ZE Ramirez, ...
MedRxiv, 2022.01. 04.21268275, 2022
232022
Racial differences in Helicobacter pylori prevalence in the US: a systematic review
HS Brown, S Cantrell, H Tang, M Epplein, KS Garman
Gastro hep advances 1 (5), 857-868, 2022
152022
Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease
ZC Holmes, H Tang, C Liu, A Bush, BC Neubert, Y Jiao, M Covington, ...
Blood, The Journal of the American Society of Hematology 140 (21), 2300-2304, 2022
132022
A novel Bromine-Containing paroxetine analogue provides mechanistic clues for binding ambiguity at the central primary binding site of the serotonin transporter
RD Slack, AM Abramyan, H Tang, S Meena, BA Davis, A Bonifazi, ...
ACS chemical neuroscience 10 (9), 3946-3952, 2019
112019
Daily lactobacillus probiotic versus placebo in COVID-19-exposed household contacts (PROTECTEHC): a randomized clinical trial [preprint]. 2022; medRxiv: 2022.01. 04.21268275
PE Wischmeyer, H Tang, Y Ren, L Bohannon, ZE Ramirez, ...
Google Scholar, 2022
92022
Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial
PE Wischmeyer, H Tang, Y Ren, L Bohannon, D Jiang, M Bergens, ...
Clinical Nutrition 43 (1), 259-267, 2024
82024
Geriatric assessment reveals actionable impairments in hematopoietic stem cell transplantation candidates age 18 to 80 years
MV Lew, Y Ren, YP Lowder, S Siamakpour-Reihani, S Ramalingam, ...
Transplantation and cellular therapy 28 (8), 498. e1-498. e9, 2022
72022
Female sex is associated with improved long-term survival following allogeneic hematopoietic stem cell transplantation
P Islam, H Tang, H Jin, F Cao, LM Bohannon, Y Ren, NJ Chao, T Choi, ...
Transplantation and cellular therapy 27 (9), 784. e1-784. e7, 2021
72021
Decreased mortality in 1-year survivors of umbilical cord blood transplant vs. matched related or matched unrelated donor transplant in patients with hematologic malignancies
L Bohannon, H Tang, K Page, Y Ren, SH Jung, A Artica, A Britt, P Islam, ...
Transplantation and cellular therapy 27 (8), 669. e1-669. e8, 2021
62021
Selective vulnerability of aneuploid human cancer cells to inhibition of the spindle assembly checkpoint
Y Cohen-Sharir, JM McFarland, M Abdusamad, C Marquis, H Tang, ...
BioRXiv, 2020.06. 18.159038, 2020
62020
Anwesha Nag, Guillaume Kugener, Beth Cimini, Peter Tsvetkov, Yosef E
U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ...
Maruvka, Ryan O’Rourke, Anthony Garrity, Andrew A. Tubelli, Pratiti …, 2018
62018
Home-based hematopoietic cell transplantation in the United States
AD Sung, VK Giri, H Tang, KR Nichols, MV Lew, L Bohannon, Y Ren, ...
Transplantation and cellular therapy 28 (4), 207. e1-207. e8, 2022
52022
SAT0162 switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis
J O'Dell, A Kivitz, T Takeuchi, Y Tanaka, I Louw, T Tiabut, S Nakashima, ...
Annals of the Rheumatic Diseases 76 (Suppl 2), 831-831, 2017
52017
Predictive performance of CAR-OLT and CAD-LT scores for post-transplant adverse cardiovascular events in a large transplant center
H Tang, C Shi, S Chapin, S Panchal, X Yu, LB VanWagner, M Serper, ...
Liver Transplantation 29 (9), 1008-1011, 2023
32023
The impact of weight loss programs on BMI trajectory in patients with metabolic dysfunction-associated steatotic liver disease: A Veterans health Administration study
H Tang, DE Kaplan, N Mahmud
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
12022
Preliminary results of a phase 1, first-in-human, dose escalation study of the anti-CCR8 cytolytic antibody, CHS-114 (formerly SRF114) in patients with advanced solid tumors.
A Patnaik, J Call, WB McKean, DW Rasco, PJ Oppelt, VN Kapoor, ...
Journal of Clinical Oncology 42 (16_suppl), 2664-2664, 2024
2024
Su1556 WEIGHT LOSS PROGRAMS AND BMI TRAJECTORY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A VETERANS HEALTH ADMINISTRATION STUDY
H Tang, DE Kaplan, N Mahmud
Gastroenterology 166 (5), S-1638, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20